PhD Student, Molecular Virology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Principal Investigator, Molecular Virology Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Indian J Public Health. 2020 Jun;64(Supplement):S147-S155. doi: 10.4103/ijph.IJPH_506_20.
The origin of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is still a debatable topic. The association of the virus spread from the market is supported by the close relation of genome sequences of environmental surface samples with virus samples from earliest patients by phylogenetic analysis.
To have an insight into the SARS-CoV-2 genome sequences reported from India for better understanding on their epidemiology and virulence.
Genome sequences of Indian isolates of SARS-CoV-2 were analyzed to understand their phylogeny and divergence with respect to other isolates reported from other countries. Amino acid sequences of individual open reading frames (ORFs) from SARS-CoV-2 Indian isolates were aligned with sequences of isolates reported from other countries to identify the mutations occurred in Indian isolates.
Our analysis suggests that Indian SARS-CoV-2 isolates are closely related to isolates reported from other parts of the world. Most ORFs are highly conserved; mutations were also detected in some ORFs. We found that most isolates reported from India have key mutations at 614 position of the S protein and 84 position of the ORF 8, which has been reported to be associated with high virulence and high transmission rate.
An attempt was made to understand the SARS-CoV-2 virus reported from India. SARS-CoV-2 reported from India was closely similar to other SARS-CoV-2 reported from other parts of the world, which suggests that vaccines and other therapeutic methods generated from other countries might work well in India. In addition, available sequence data suggest that majority of Indian isolates are capable of high transmission and virulence.
严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的起源仍然是一个有争议的话题。通过系统进化分析,环境表面样本的基因组序列与最早患者的病毒样本密切相关,这支持了病毒从市场传播的关联。
深入了解从印度报告的 SARS-CoV-2 基因组序列,以便更好地了解其流行病学和毒力。
分析印度分离的 SARS-CoV-2 基因组序列,以了解其与其他国家报告的分离株的系统进化和差异。用来自其他国家报告的分离株的序列对 SARS-CoV-2 印度分离株的各个开放阅读框(ORF)的氨基酸序列进行比对,以确定印度分离株中发生的突变。
我们的分析表明,印度 SARS-CoV-2 分离株与来自世界其他地区报告的分离株密切相关。大多数 ORF 高度保守;在一些 ORF 中也检测到突变。我们发现,印度报告的大多数分离株在 S 蛋白的 614 位和 ORF8 的 84 位有关键突变,这与高毒力和高传播率有关。
尝试了解从印度报告的 SARS-CoV-2 病毒。从印度报告的 SARS-CoV-2 与从世界其他地区报告的其他 SARS-CoV-2 非常相似,这表明从其他国家生成的疫苗和其他治疗方法可能在印度有效。此外,现有序列数据表明,大多数印度分离株具有较高的传播和毒力。